Evidence map›Paper›PMID 27228906›Full record

SynthesisScientific reports2016

Robotic-assisted surgery versus open surgery in the treatment of rectal cancer: the current evidence.

Guixiang Liao, Yan-Bing Li, Zhihong Zhao, Xianming Li, Haijun Deng, Gang Li

Open access · goldAbstract readMeta-Analysis
In one paragraph

Synthesis in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 5 pooled it
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 5 syntheses or guidelines pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. [Robotic-assisted surgery of rectal cancer-Technique, limitations and results].Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen · 2021
    Review
  17. Article
  18. Article
  19. Robotics Total Mesorectal Excision Up To the Minute.Indian journal of surgical oncology · 2020
    Review
  20. Robotic surgery for colorectal cancer.Annals of gastroenterological surgery · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 1 country.

Guixiang LiaoDepartment of Radiation Oncology, Shenzhen People's Hospital, Second Clinical Medicine College of Jinan University, China.
Yan-Bing LiDepartment of Hepatobiliary and Pancreatic Surgery, Taihe Hospital, Hubei University of Medicine, Hubei, China.
Zhihong ZhaoDepartment of Nephrology, The Third Affiliated Hospital of Southern Medical University, Guangzhou, Guangdong, China.
Xianming LiDepartment of Radiation Oncology, Shenzhen People's Hospital, Second Clinical Medicine College of Jinan University, China.
Haijun DengDepartment of General Surgery, Nanfang Hospital of Southern Medical University, Guangzhou, Guangdong, China.
Gang LiDepartment of Chemoradiation Oncology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Jinan University · CNNanfang Hospital · CNTaihe Hospital · CNThird Affiliated Hospital of Southern Medical University · CNWenzhou Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this meta-analysis was to comprehensively compare the safety and efficacy of robotic-assisted rectal cancer surgery (RRCS) and open rectal cancer surgery (ORCS). Electronic database (PubMed, EMBASE, Web of Knowledge, and the Cochrane Library) searches were conducted for all relevant studies that compared the short-term and long-term outcomes between RRCS and ORCS. Odds ratios (ORs), mean differences, and hazard ratios were calculated. Seven studies involving 1074 patients with rectal cancer were identified for this meta-analysis. Compared with ORCS, RRCS is associated with a lower estimated blood loss (mean difference [MD]: -139.98, 95% confidence interval [CI]: -159.11 to -120.86; P < 0.00001), shorter hospital stay length (MD: -2.10, 95% CI: -3.47 to -0.73; P = 0.003), lower intraoperative transfusion requirements (OR: 0.52, 95% CI: 0.28 to 0.99, P = 0.05), shorter time to flatus passage (MD: -0.97, 95% CI = -1.06 to -0.88, P < 0.00001), and shorter time to resume a normal diet (MD: -1.71.95% CI = -3.31 to -0.12, P = 0.04). There were no significant differences in surgery-related complications, oncologic clearance, disease-free survival, and overall survival between the two groups. However, RRCS was associated with a longer operative time. RRCS is safe and effective.

Indexed as

Blood Loss, SurgicalBlood TransfusionHumansLaparoscopyLength of StayOdds RatioOperative TimePostoperative ComplicationsProspective StudiesRectal NeoplasmsRetrospective StudiesRobotic Surgical ProceduresSurvival AnalysisTreatment Outcome

Identifiers

PMID27228906
PMCPMC4882598
OpenAlexW2407590110

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.